| FM-AD |
▾ 23 Disease Types |
▾ 42 Primary Sites |
FM |
18004 |
|
GENIE-MSK
|
▾ 49 Disease Types |
▾ 49 Primary Sites |
GENIE |
16824 |
|
GENIE-DFCI
|
▾ 53 Disease Types |
▾ 49 Primary Sites |
GENIE |
14232 |
|
GENIE-MDA
|
▾ 34 Disease Types |
▾ 42 Primary Sites |
GENIE |
3857 |
|
GENIE-JHU
|
▾ 33 Disease Types |
▾ 32 Primary Sites |
GENIE |
3320 |
|
GENIE-UHN
|
▾ 37 Disease Types |
▾ 42 Primary Sites |
GENIE |
2632 |
|
TARGET-AML
|
▾ 2 Disease Types |
▾ 2 Primary Sites |
TARGET |
2146 |
|
GENIE-VICC
|
▾ 41 Disease Types |
▾ 46 Primary Sites |
GENIE |
2052 |
|
TARGET-ALL-P2
|
Lymphoid Leukemias |
▾ 2 Primary Sites |
TARGET |
1587 |
|
TARGET-NBL
|
▾ 2 Disease Types |
▾ 20 Primary Sites |
TARGET |
1132 |
|
TCGA-BRCA
|
▾ 9 Disease Types |
Breast |
TCGA |
1098 |
|
GENIE-GRCC
|
▾ 33 Disease Types |
▾ 45 Primary Sites |
GENIE |
1038 |
|
MMRF-COMMPASS
|
Plasma Cell Tumors |
Hematopoietic and reticuloendothelial systems |
MMRF |
995 |
|
GENIE-NKI
|
▾ 23 Disease Types |
▾ 42 Primary Sites |
GENIE |
801 |
|
TARGET-WT
|
Complex Mixed and Stromal Neoplasms |
Kidney |
TARGET |
652 |
|
TCGA-GBM
|
▾ 2 Disease Types |
Brain |
TCGA |
617 |
|
TCGA-OV
|
▾ 2 Disease Types |
Ovary |
TCGA |
608 |
|
TCGA-LUAD
|
▾ 3 Disease Types |
Bronchus and lung |
TCGA |
585 |
|
BEATAML1.0-COHORT
|
▾ 9 Disease Types |
Hematopoietic and reticuloendothelial systems |
BEATAML1.0 |
583 |
|
TCGA-UCEC
|
▾ 4 Disease Types |
▾ 2 Primary Sites |
TCGA |
560 |
|
CPTAC-3
|
▾ 4 Disease Types |
▾ 5 Primary Sites |
CPTAC |
540 |
|
TCGA-KIRC
|
Adenomas and Adenocarcinomas |
Kidney |
TCGA |
537 |
|
TCGA-HNSC
|
Squamous Cell Neoplasms |
▾ 13 Primary Sites |
TCGA |
528 |
|
TCGA-LGG
|
Gliomas |
Brain |
TCGA |
516 |
|
TCGA-THCA
|
▾ 2 Disease Types |
Thyroid gland |
TCGA |
507 |
|
TCGA-LUSC
|
Squamous Cell Neoplasms |
Bronchus and lung |
TCGA |
504 |
|
TCGA-PRAD
|
▾ 3 Disease Types |
Prostate gland |
TCGA |
500 |
|
NCICCR-DLBCL
|
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
Lymph Nodes |
NCICCR |
489 |
|
TCGA-SKCM
|
Nevi and Melanomas |
Skin |
TCGA |
470 |
|
TCGA-COAD
|
▾ 4 Disease Types |
▾ 2 Primary Sites |
TCGA |
461 |
|
TCGA-STAD
|
▾ 2 Disease Types |
Stomach |
TCGA |
443 |
|
TCGA-BLCA
|
▾ 4 Disease Types |
Bladder |
TCGA |
412 |
|
TARGET-OS
|
Osseous and Chondromatous Neoplasms |
▾ 3 Primary Sites |
TARGET |
383 |
|
TCGA-LIHC
|
Adenomas and Adenocarcinomas |
Liver and intrahepatic bile ducts |
TCGA |
377 |
|
CPTAC-2
|
▾ 5 Disease Types |
▾ 6 Primary Sites |
CPTAC |
342 |
|
TCGA-CESC
|
▾ 4 Disease Types |
Cervix uteri |
TCGA |
307 |
|
TCGA-KIRP
|
Adenomas and Adenocarcinomas |
Kidney |
TCGA |
291 |
|
TCGA-SARC
|
▾ 6 Disease Types |
▾ 13 Primary Sites |
TCGA |
261 |
|
CGCI-HTMCP-CC
|
▾ 4 Disease Types |
Cervix uteri |
CGCI |
212 |
|
TCGA-LAML
|
Myeloid Leukemias |
Hematopoietic and reticuloendothelial systems |
TCGA |
200 |
|
TARGET-ALL-P3
|
▾ 5 Disease Types |
▾ 2 Primary Sites |
TARGET |
191 |
|
TCGA-PAAD
|
▾ 4 Disease Types |
Pancreas |
TCGA |
185 |
|
TCGA-ESCA
|
▾ 3 Disease Types |
▾ 2 Primary Sites |
TCGA |
185 |
|
TCGA-PCPG
|
Paragangliomas and Glomus Tumors |
▾ 7 Primary Sites |
TCGA |
179 |
|
OHSU-CNL
|
Chronic Myeloproliferative Disorders |
Hematopoietic and reticuloendothelial systems |
OHSU |
176 |
|
TCGA-READ
|
▾ 2 Disease Types |
▾ 5 Primary Sites |
TCGA |
172 |
|
TCGA-TGCT
|
Germ Cell Neoplasms |
Testis |
TCGA |
150 |
|
TCGA-THYM
|
Thymic Epithelial Neoplasms |
▾ 2 Primary Sites |
TCGA |
124 |
|
CGCI-BLGSP
|
Mature B-Cell Lymphomas |
Hematopoietic and reticuloendothelial systems |
CGCI |
120 |
|
TCGA-KICH
|
Adenomas and Adenocarcinomas |
Kidney |
TCGA |
113 |
|
WCDT-MCRPC
|
Adenomas and Adenocarcinomas |
Prostate gland |
WCDT |
101 |
|
TCGA-ACC
|
Adenomas and Adenocarcinomas |
Adrenal gland |
TCGA |
92 |
|
TCGA-MESO
|
Mesothelial Neoplasms |
▾ 2 Primary Sites |
TCGA |
87 |
|
TCGA-UVM
|
Nevi and Melanomas |
Eye and adnexa |
TCGA |
80 |
|
ORGANOID-PANCREATIC
|
▾ 2 Disease Types |
Pancreas |
ORGANOID |
70 |
|
TARGET-RT
|
Complex Mixed and Stromal Neoplasms |
▾ 3 Primary Sites |
TARGET |
69 |
|
TCGA-DLBC
|
▾ 2 Disease Types |
▾ 14 Primary Sites |
TCGA |
58 |
|
TCGA-UCS
|
Complex Mixed and Stromal Neoplasms |
Uterus, NOS |
TCGA |
57 |
|
BEATAML1.0-CRENOLANIB
|
Myeloid Leukemias |
Hematopoietic and reticuloendothelial systems |
BEATAML1.0 |
56 |
|
TCGA-CHOL
|
Adenomas and Adenocarcinomas |
▾ 3 Primary Sites |
TCGA |
51 |
|
CTSP-DLBCL1
|
▾ 2 Disease Types |
▾ 2 Primary Sites |
CTSP |
45 |
|
TARGET-ALL-P1
|
Lymphoid Leukemias |
Hematopoietic and reticuloendothelial systems |
TARGET |
24 |
|
HCMI-CMDC
|
▾ 5 Disease Types |
▾ 8 Primary Sites |
HCMI |
23 |
|
TARGET-CCSK
|
Complex Mixed and Stromal Neoplasms |
Kidney |
TARGET |
13 |
|
VAREPOP-APOLLO
|
▾ 2 Disease Types |
Bronchus and lung |
VAREPOP |
7 |